27 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 34 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 34 | Completed 27, Recruiting 2, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 9 | Completed 8, Recruiting 1 |
Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NTI164 in Autism Spectrum Disorder NTI164, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Not yet recruiting | Fenix Innovation Group | 200 | 2026-09-30 | 2026-09-30 |
| Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders PostbiotiX Comfort®, Control - Autism, Autism Disorder | Phase 2 / Phase 3 | Recruiting | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 90 | 2023-03-21 | 2026-03-04 |
| Role of Bumetanide in Treatment of Autism Bumetanide, Placebo - Autism | Phase 3 | Recruiting | Sherief Abd-Elsalam | 80 | 2021-01-01 | 2021-02-23 |
| Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions Memantine Hydrochloride, Placebo - Autism, Autism Spectrum Disorder | Phase 3 | Terminated | Massachusetts General Hospital | 25 | 2018-11-13 | 2026-02-25 |
| Intranasal Vasopressin Treatment in Children With Autism Vasopressin (USP) Injectable Solution [Vasostrict], Placebo - Autism, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Stanford University | 157 | 2018-02-20 | 2026-06-04 |
| Open Label of Clinical Trial of Sulforaphane in Children With Autism Sulforaphane - Autism | Phase 3 | Completed | University of California, San Francisco | 21 | 2016-01-01 | 2019-03-06 |
| An Open Label Study of CM-AT for the Treatment of Children With Autism CM-AT - Autism | Phase 3 | Active not recruiting | Curemark | 405 | 2015-10-01 | 2026-03-18 |
| A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) CM-AT, PLACEBO - Autism | Phase 3 | Completed | Curemark | 190 | 2015-05-13 | 2023-05-24 |
| Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD) Auditory-Motor Mapping Training, Speech-Repetition Therapy - Autism | Phase 2 / Phase 3 | Completed | Beth Israel Deaconess Medical Center | 14 | 2014-11-01 | 2020-05-19 |
| Pediatric Open-Label Extension Study Lurasidone 20, 40, 60, 80 mg, flexibly dosed - Schizophrenia, Autism | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 702 | 2013-09-30 | 2019-12-19 |
| Lurasidone Pediatric Autism Study Lurasidone 20 mg daily, Lurasidone, Placebo - Autism | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 150 | 2013-08-01 | 2016-02-25 |
| Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders Autologous Intrathecal Hematopoietic Stem Cells, Observation with IDEA and CARS Scales - Autism, Autism Spectrum | Phase 3 | Completed | Hospital Universitario Dr. Jose E. Gonzalez | 30 | 2012-11-01 | 2025-09-16 |
| Parent-delivered Massage for Children With Autism Parent massage tx group, Parent massage wait-list control group - Autism | Phase 2 / Phase 3 | Completed | Western Oregon University | 103 | 2012-09-01 | 2016-04-29 |
| Open Label Clinical Trial of Vitamin D in Children With Autism Liquid Vitamin D - Autism, Vitamin D Deficiency | Phase 2 / Phase 3 | Completed | University of California, San Francisco | 10 | 2012-02-01 | 2019-10-09 |
| Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders Cognitive-behavioral therapy, Treatment as Usual - Autism, Asperger's Syndrome | Phase 2 / Phase 3 | Completed | University of South Florida | 45 | 2010-04-01 | 2013-04-02 |
| A Trial of CM-AT in Children With Autism- Open Label Extension Study CM-AT - Autism | Phase 3 | Completed | Curemark | 165 | 2010-01-01 | 2019-03-01 |
| A Trial of CM-AT in Children With Autism CM-AT, Placebo - Autism | Phase 3 | Completed | Curemark | 182 | 2009-05-01 | 2018-04-19 |
| Pharmacogenomics in Autism Treatment Risperidone - Autism | Phase 2 / Phase 3 | Completed | University of California, San Francisco | 49 | 2008-01-01 | 2012-07-24 |
| Study of Paliperidone ER in Adolescents and Young Adults With Autism Paliperidone ER - Autism | Phase 3 | Completed | Indiana University | 25 | 2007-11-01 | 2017-05-16 |
| Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism Hyperbaric Oxygen Treatment (HBOT) - Autism | Phase 3 | Completed | University of California, San Francisco | 10 | 2007-10-01 | 2012-08-07 |
Showing 20 of 34. Sign in to see all of them.
Autistic Disorder (34) · Autism Spectrum Disorder (10) · Attention Deficit Disorder with Hyperactivity (2) · Anxiety Disorders (1) · Anxiety, Separation (1) · Asperger Syndrome (1) · Bipolar Disorder (1) · Child Development Disorders, Pervasive (1) · Generalized Anxiety Disorder (1) · Marijuana Abuse (1) · Obsessive-Compulsive Disorder (1) · Phobia, Social (1) · Schizophrenia (1) · Vitamin D Deficiency (1) · non-verbal learning disabilities (1)
Mental Disorders (34) · Neurodevelopmental Disorders (34) · Child Development Disorders, Pervasive (33) · Autism Spectrum Disorder (24) · Attention Deficit and Disruptive Behavior Disorders (2) · Avitaminosis (1) · Bipolar and Related Disorders (1) · Chemically-Induced Disorders (1) · Deficiency Diseases (1) · Malnutrition (1) · Mood Disorders (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Phobic Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Secretin (3) · Lurasidone Hydrochloride (2) · Methylphenidate (2) · Acupuncture Therapy (1) · Arginine Vasopressin (1) · Atomoxetine Hydrochloride (1) · Bumetanide (1) · Citric Acid (1) · Cognitive Behavioral Therapy (1) · Counseling (1) · Fluvoxamine (1) · Galantamine (1) · Memantine (1) · Observation (1) · Olanzapine (1)
Curemark (4) · The University of Hong Kong (4) · University of California, San Francisco (4) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Massachusetts General Hospital (2) · Repligen Corporation (2) · Sumitomo Pharma America, Inc. (2) · Beth Israel Deaconess Medical Center (1) · Drexel University (1) · Fenix Innovation Group (1) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · Indiana University (1) · Sherief Abd-Elsalam (1) · Stanford University (1)
United States (22) · Hong Kong (4) · Mexico (2) · Australia (1) · Bulgaria (1) · Canada (1) · Colombia (1) · Egypt (1) · France (1) · Hungary (1) · Italy (1) · Malaysia (1) · Philippines (1) · Poland (1) · Puerto Rico (1)
Wong Virginia (4) · Robert Hendren, DO (3) · Robert L Hendren, DO (3) · Deborah Pearson, PhD (2) · Abeer Salamah, Dr (1) · Alan Unis, MD (1) · Antonio Y. Hardan, M.D. (1) · Christopher J. McDougle, MD (1) · David Dunn, MD (1) · Deborah A. Pearson, PhD (1) · Edward Goldson, MD (1) · Eric A Storch, Ph.D. (1) · Esraa Shaker, Msc (1) · Eugene Arnold, MD (1)
PMID 37811711, PMID 38032645, PMID 21818676, PMID 23357440, PMID 25878901, PMID 29854372, PMID 34324397, PMID 36006807, PMID 37267443
K08MH001516 (1), P01HD035465 (1), P01HD035468 (1), R01HD091972 (1), R01MH072263 (1), R01MH073524 (1), R01MH077600 (1), R21MH080026 (1)